INS and type 2 diabetes mellitus: In a first-in-human study evaluating the feasibility, safety, and efficacy of ReCET in patients with T2D on basal insulin, 14 patients underwent ReCET, followed by semaglutide initiation, with insulin discontinued after the procedure.